info_outline
Brains, Blood, and Beyond 🧠🩸🚀: GLP-1RAs for Mind, Metabolism and Mortality
07/20/2025
Brains, Blood, and Beyond 🧠🩸🚀: GLP-1RAs for Mind, Metabolism and Mortality
New Study Alert! 🧠💉📉 Exciting real-world evidence shows that GLP-1 receptor agonists—semaglutide and tirzepatide—not only help with type 2 diabetes and obesity but may also reduce the risk of dementia, stroke, and all-cause mortality! 🙌📊 In a cohort of over 60,000 patients, these agents delivered neuroprotective and cerebrovascular benefits beyond glycemic control. Benefits were especially notable in older adults, women, and those with BMI 30–40. 💪👵🧬 🔗 If you’re passionate about brain health, diabetes, and the expanding therapeutic role of GLP-1RAs—this is a must-read! 📄 Published in JAMA Network Open | July 2025 📌 #GLP1 #Semaglutide #Tirzepatide #Dementia #Stroke #Diabetes #Neuroprotection #CardiometabolicHealth #JAMA #RealWorldEvidence #LongevityMedicine
/episode/index/show/drbaligasinternalmedicinepodcasts/id/37465420